Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Ikena, after tough year of layoffs, merges with Inmagene
After a year that saw Ikena trim its workforce and pipeline, the oncology biotech thinks it’s found a path forward via a merger into Inmagene.
James Waldron
Dec 23, 2024 10:00am
Ph. 2 data will drive biopharma VC investment in 2025: PitchBook
Dec 23, 2024 4:33am
Aadi buys preclinical ADCs, sells Fyarro to reboot business
Dec 20, 2024 3:54am
Fierce Biotech Fundraising Tracker: Ottimo, SiteOne & more
Dec 19, 2024 12:00pm
VC firm pens $608M deal to direct NGM MASH drug to rare disease
Dec 19, 2024 10:30am
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
Dec 19, 2024 6:58am
